Postdoctoral fellow in immuno-oncology (F/M) (F/M)
75005, Paris, France
Working environment and context
Our institution is part of PSL University. Located in the heart of Paris, it brings together all areas of knowledge, innovation and creation. Ranked among the top 50 universities in the world, it trains researchers, artists, engineers, entrepreneurs and managers who are aware of their social, individual and collective responsibility in the field of research.
Hosting structure
The Curie Institute Research Center
The “Institut Curie” is a major player in the research and fight against cancer. It consists of a hospital and a Research Center of more than 1000 employees with a strong international representativeness.
The objective of the Curie Institute Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis, prognosis, and therapeutics of cancers as part of the continuum between basic research and innovation serving the patient.
.
Missions
Main tasks
Laboratory
Institut Curie is one of the largest European institutions for cancer and biomedical research with strong interdisciplinary traditions. It is located in the center of Paris in France, in a both cultural and scientific rich environment. The site has active seminar program and hosts regular training sessions in molecular and cellular biology. The project will be developed in Center of Cancer Immunotherapy headed by Dr S. Amigorena and the Clinic Immunology Laboratory headed by Dr O. Lantz. The Immunology Department headed by Dr. AM Lennon includes 8 independent research teams in the fields of basic and applied immunology, working in a very collaborative and international environment. Candidate will work under the supervision of Dr. Olivier Lantz and Dr. F. Lucibello. The aim of the team is to characterize the biology of T cells, their interaction with other cells of the immune system, and their role in cancer, in both humans and through mice models. The open position is in line with recent developments at the interface between Immunology and Cancer (Bigot et al. Cancer Discovery, 2021; Lucibello et al., JEM, 2024). More information: www.curie.fr and http://u932.curie.fr/.
Missions
The research group of Dr. Olivier Lantz (Inserm U932, Paris, France) is seeking a postdoctoral fellow in immunology and oncology. The successful candidate will work on projects focused on the identification and validation of tumor-specific neoantigens shared between patients with non-small cell lung cancer NSCLC.
The project aims to characterize tumor-specific T cell responses directed against neoantigens in human cancer. In silico–predicted neoantigens will be evaluated using immunopeptidomics approaches. Following the identification of the most promising epitopes, their spontaneous immunogenicity and the T cell responses they elicit in patients will be assessed.
Immune responses induced in NSCLC patients treated with immunotherapy will be analyzed in both blood, tumor draining lymphonode and tumor samples. Tumor-specific T cells will be studied using flow cytometry, single-cell technologies (including single-cell RNA sequencing), tetramer staining, and functional assays such as in vitro T cell culture and cytotoxicity (killing) assays. Bioinformatics skills will be considered a strong asset.
The candidate will work in close collaboration with two engineers within the research team and with F. Lucibello.
Applicant profile
Knowkedge and qualifications expected
• PhD in immunology, molecular and cellular biology, or biothechnology
• Knowledge in human immunology, oncology and immunotherapy
• Expertise in flow cytometry is mandatory
• Scientific rigor and excellent analytical and synthetic capabilities
• Team spirit and dynamic personality with passion for innovation and problem-solving
• Good proficiency in English
All our opportunities are open to people with disabilities
Contract information
Type of contract: CDD
Starting date: as soon as possible
Duration: 18 months to 3 years
Working time: full time
Remuneration: according to the current grids
Benefits: Collective catering, reimbursement of transportation fees up to 70%, supplementary health insurance
Location of the position: Paris
Contact
Please send your CV, letter of motivation and 2 references
Publication date: 11 Feb 2026
Deadline for application: until filled
Institut Curie is an inclusive, equal opportunity employer
and is dedicated to the highest standards of research integrity.
https://euraxess.ec.europa.eu/sites/default/files/brochures/eur_21620_en-fr.pdf
Diplôme et expérience professionnelle
Bac+6 et plusNon discrimination, openness and transparency
Our institution, like PSL University as a whole, is committed to supporting and promoting equality, diversity and inclusion within its communities. We encourage applications from a variety of backgrounds, which we will ensure are selected through an open and transparent recruitment process.
Contact
ftdl8hoqnh5k@emploi.beetween.com
Other information
Postdoctoral fellow in immuno-oncology (F/M) (F/M)
| Location 75005, Paris, France |
|---|
| School Institut Curie |
Working environment and context
Notre établissement fait partie de l'Université PSL. Située au cœur de Paris, celle-ci fait dialoguer tous les domaines du savoir, de l'innovation et de la création. Classée parmi les 50 premières universités mondiales, elle forme au plus près de la recherche des chercheurs, artistes, ingénieurs, entrepreneurs ou dirigeants conscients de leur responsabilité sociale, individuelle et collective.
Hosting structure
The Curie Institute Research Center
The “Institut Curie” is a major player in the research and fight against cancer. It consists of a hospital and a Research Center of more than 1000 employees with a strong international representativeness.
The objective of the Curie Institute Research Center is to develop basic research and to use the knowledge produced to improve the diagnosis, prognosis, and therapeutics of cancers as part of the continuum between basic research and innovation serving the patient.
.
Missions
Main tasks
Laboratory
Institut Curie is one of the largest European institutions for cancer and biomedical research with strong interdisciplinary traditions. It is located in the center of Paris in France, in a both cultural and scientific rich environment. The site has active seminar program and hosts regular training sessions in molecular and cellular biology. The project will be developed in Center of Cancer Immunotherapy headed by Dr S. Amigorena and the Clinic Immunology Laboratory headed by Dr O. Lantz. The Immunology Department headed by Dr. AM Lennon includes 8 independent research teams in the fields of basic and applied immunology, working in a very collaborative and international environment. Candidate will work under the supervision of Dr. Olivier Lantz and Dr. F. Lucibello. The aim of the team is to characterize the biology of T cells, their interaction with other cells of the immune system, and their role in cancer, in both humans and through mice models. The open position is in line with recent developments at the interface between Immunology and Cancer (Bigot et al. Cancer Discovery, 2021; Lucibello et al., JEM, 2024). More information: www.curie.fr and http://u932.curie.fr/.
Missions
The research group of Dr. Olivier Lantz (Inserm U932, Paris, France) is seeking a postdoctoral fellow in immunology and oncology. The successful candidate will work on projects focused on the identification and validation of tumor-specific neoantigens shared between patients with non-small cell lung cancer NSCLC.
The project aims to characterize tumor-specific T cell responses directed against neoantigens in human cancer. In silico–predicted neoantigens will be evaluated using immunopeptidomics approaches. Following the identification of the most promising epitopes, their spontaneous immunogenicity and the T cell responses they elicit in patients will be assessed.
Immune responses induced in NSCLC patients treated with immunotherapy will be analyzed in both blood, tumor draining lymphonode and tumor samples. Tumor-specific T cells will be studied using flow cytometry, single-cell technologies (including single-cell RNA sequencing), tetramer staining, and functional assays such as in vitro T cell culture and cytotoxicity (killing) assays. Bioinformatics skills will be considered a strong asset.
The candidate will work in close collaboration with two engineers within the research team and with F. Lucibello.
Applicant profile
Knowkedge and qualifications expected
• PhD in immunology, molecular and cellular biology, or biothechnology
• Knowledge in human immunology, oncology and immunotherapy
• Expertise in flow cytometry is mandatory
• Scientific rigor and excellent analytical and synthetic capabilities
• Team spirit and dynamic personality with passion for innovation and problem-solving
• Good proficiency in English
All our opportunities are open to people with disabilities
Contract information
Type of contract: CDD
Starting date: as soon as possible
Duration: 18 months to 3 years
Working time: full time
Remuneration: according to the current grids
Benefits: Collective catering, reimbursement of transportation fees up to 70%, supplementary health insurance
Location of the position: Paris
Contact
Please send your CV, letter of motivation and 2 references
Publication date: 11 Feb 2026
Deadline for application: until filled
Institut Curie is an inclusive, equal opportunity employer
and is dedicated to the highest standards of research integrity.
https://euraxess.ec.europa.eu/sites/default/files/brochures/eur_21620_en-fr.pdf
Diplôme et expérience professionnelle
Bac+6 et plusNon discrimination, ouverture et transparence
Notre établissement, comme l'ensemble de l'Université PSL, s’engage à soutenir et promouvoir l’égalité, la diversité et l’inclusion au sein de ses communautés. Nous encourageons les candidatures issues de profils variés, que nous veillerons à sélectionner via un processus de recrutement ouvert et transparent.
Contact
ftdl8hoqnh5k@emploi.beetween.com
Other information
| Reference ftdl8hoqnh |
|---|
Université PSL (Paris Sciences & Lettres)
